CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare institutions need to advance robotic-assisted surgery,” said CEO Massimiliano ...

Globally, Versius is the second most utilized surgical robotic system, withover26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact ...

December 2025CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical systemRegulatory clearance of CMR’s most advanced ...

Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR's most advanced system paves the way for upcoming US commercial launch Strong clinical ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global ...